Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial

ST. LOUIS, July 12, 2021 /PRNewswire/ — Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the enrollment of its first patients in the CRC-PREVENT pivotal trial. The clinical study seeks to evaluate the…

About the Author

has written 21793 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com